SBMC invests 4 million euro in New Pilot Production Facility for biomaterials
Smart BioMaterials Consortium (SBMC) and High Tech Campus Eindhoven have joined forces to establish a pilot production facility for smart biomaterials.
Expected to open in 2025, the SBMC production facility will house four GMP cleanrooms spanning 400 square meters, a quality control laboratory, and office and warehouse space. SBMC invites companies, both within and beyond the consortium, to tap into theirhttps://regmedxb.com/pilot-factory expertise and shared facilities to address scaling and production challenges.
The pilot production facility of SBMC is part of the RegMed XB Pilot Factory for Regenerative Medicine, supported by the National Growth Fund.
For further details, visit SBMC's website.
Related:
There are no up-coming events
Latest news
- A Major Advancement for RegMed XB’s Diabetes Moonshot
- Phlox Therapeutics, is developing RNA-based therapies for genetic cardiomyopathies
- Annual Conference 2025 registration is open!
- RegMed XB is awarded to be one of the selected programs by Health~Holland
- 2024 in Review: RegMed XB Highlights
- RegMed XB 3rd Annual Conference 2025